Type 2 diabetes (T2D) confers a high risk of heart failure frequently with evidence of
cardiovascular structural and functional abnormalities before symptom onset. The effects of …

Background Vasculogenic therapies explored for the treatment of peripheral artery disease
(PAD) have encountered minimal success in clinical trials. Addressing this, B55α, an isoform …

The Mammalian Gene Collection Project enabled the discovery of a novel kidney enzyme,
subsequently named renalase (1, 2) in 2005. Renalase was initially identified in proximal …

Аннотация С ростом продолжительности жизни происходит увеличение количества
пожилых людей среди населения, поэтому важной задачей для российского …

SGLT2 (Sodium-glucose Cotransporter-2) inhibitors are newer glucose-lowering drugs with
many cardiovascular benefits that are not fully understood yet. Endothelial integrity plays a …

Diabetes mellitus (DM) has been the most common disease and International Diabetes
Federation (IDF)-2021 reports that there are 541 million people with impaired glucose …

За результатами дослідження було запропоноване нове вирішення нагальної
проблеми сучасної кардіології-удосконалення прогнозування та діагностики хронічної …

A subset of non-communicable diseases, presently turning into a big economic burden
worldwide, is interestingly a consequence of lately modified socio-economic stature globally …

Cardiovascular disease (CVD) is the leading cause of death in people with type 1 diabetes
(T1D). Both the endothelin system and skeletal muscle mitochondria play important roles in …

The preeclampsia etiology is unclearly understood, becoming considerable concern as an
aging-related disease. Accelerated prematurity of cell death associated with decreased …